Health Care: Drugs

Cubist Pharmaceuticals Inc (CBST: NASDAQ)

$69.03 n/a | n/a%
08/29/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.05B 926.36M 753.97M 636.46M
Cost of Sales 182.99M 168.75M 132.62M 104.99M
Gross Operating Profit 871.46M 757.61M 621.35M 531.46M
Selling, General, and Administrative Expenses 257.94M 171.79M 254.76M 148.24M
Research & Development 477.74M 277.73M 184.53M 157.85M
Operating Income before D & A (EBITDA) 135.78M 308.09M 182.06M 225.37M
Depreciation & Amortization 77.32M 61.31M 40.25M 35.77M
Interest Income 2.44M 3.08M 2.67M 4.70M
Other Income - Net -34.89M -7.60M 1.00M -14.41M
Special Income / Charges -7.72M -9.68M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -6.04M 232.59M 136.20M 179.89M
Interest Expense 37.60M 32.99M 31.42M 25.58M
Pre-Tax Income -43.64M 199.60M 104.79M 154.31M
Income Taxes -25.07M 45.52M 71.77M 59.98M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -18.57M 154.08M 33.02M 94.32M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -18.57M 154.08M 33.02M 94.32M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -18.57M 154.08M 33.02M 94.32M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
13.47M 163.75M 42.30M 94.32M
Preferred Dividends
Net Income Available To Common -18.57M 154.08M 33.02M 94.32M
Basic EPS from Continuing Ops. -0.27 2.42 0.54 1.60
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.27 2.42 0.54 1.60
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.27 2.42 0.54 1.60
Basic Normalized Net Income/Share 0.20 2.57 0.70 1.60
EPS fr Continuing Ops. -0.27 1.89 0.52 1.51
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.27 1.89 0.52 1.51
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.21 0.00 0.04
EPS, Total -0.27 2.10 0.52 1.55
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.20 2.01 0.67 1.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CBST

Latest CBST Headlines from TheStreet

More Financial News for CBST

Press Releases for CBST

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter